2014
DOI: 10.1152/ajpheart.00106.2014
|View full text |Cite
|
Sign up to set email alerts
|

The American Journal of Physiology-Heart and Circulatory Physiology: a long history, a bright future

Abstract: IN 1887 AFTER THE CIVIL WAR, the American Physiological Society (APS) was founded by five clinician scientists (12). Silas Weir Mitchell was, by training, a neurologist, and Henry Pickering Bowditch was a cardiovascular physiologist who had trained in Germany with Carl Ludwig. They joined Henry Newell Martin, an Irish-born cardiovascular physiologist from Johns Hopkins; Russell Henry Chittenden, a biochemist from Yale; and John Green Curtis, a surgeon from Columbia University. The first issue of The American J… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 17 publications
0
3
0
Order By: Relevance
“…Many trials have been done in the bench and at the bedside, leaving promising results . In the case of MI, one of the most promising benefits of cell therapy is the potential for cardiac tissue regeneration to reverse the tissue loss underlying the development of heart failure after cardiac injury . Despite this new era opened by cell therapy, the low efficacy has limited its potential as a therapeutic tool .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Many trials have been done in the bench and at the bedside, leaving promising results . In the case of MI, one of the most promising benefits of cell therapy is the potential for cardiac tissue regeneration to reverse the tissue loss underlying the development of heart failure after cardiac injury . Despite this new era opened by cell therapy, the low efficacy has limited its potential as a therapeutic tool .…”
Section: Discussionmentioning
confidence: 99%
“…14,16 In the case of MI, one of the most promising benefits of cell therapy is the potential for cardiac tissue regeneration to reverse the tissue loss underlying the development of heart failure after cardiac injury. 17 Despite this new era opened by cell therapy, the low efficacy has limited its potential as a therapeutic tool. 14 Clinical meta-analyses have reported a modest 3% improvement (range 1.9% to 4.5%) in left ventricle ejection fraction, indicating that transition to the clinic may have occurred too quickly.…”
Section: Cell Therapy For MImentioning
confidence: 99%
“…One of the vital signals that carry medical information about cardiovascular system conditions is the central blood pressure signals [1], [2]. The clinical protocols of measuring this signal are usually burdensome as they can only be measured invasively with a catheter.…”
Section: Introductionmentioning
confidence: 99%